Literature DB >> 2299193

Increased collagen synthesis accompanying elevated m-RNA levels in cultured Werner's syndrome fibroblasts.

M Arakawa1, A Hatamochi, K Takeda, H Ueki.   

Abstract

Although Werner's syndrome (WS) is a premature aging disease and its fibroblasts typically grow poorly in culture, WS may cause abnormalities in connective tissue metabolism that are seldom seen in normal aging, such as scleroderma-like skin. In a preliminary report, we described increased collagen synthesis in fibroblasts derived from two WS patients. The present study was undertaken to determine the degree of the regulation of collagen gene expression in dermal fibroblasts from two other patients. Overproduction of collagenase sensitive protein was observed in WS fibroblasts. Collagen m-RNA levels, that were determined by hybridization of RNA blots with specific cDNA were about 2 times greater than those in the control cells. These results suggest that control of collagen synthesis in WS fibroblasts is altered at the transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299193     DOI: 10.1111/1523-1747.ep12874489

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  siRNA knockdown of tissue inhibitor of metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I.

Authors:  Masayo Aoki; Koichi Miyake; Rei Ogawa; Teruyuki Dohi; Satoshi Akaishi; Hiko Hyakusoku; Takashi Shimada
Journal:  J Invest Dermatol       Date:  2013-09-16       Impact factor: 8.551

Review 2.  The effects of ageing on cutaneous wound healing in mammals.

Authors:  G S Ashcroft; M A Horan; M W Ferguson
Journal:  J Anat       Date:  1995-08       Impact factor: 2.610

3.  The transcription of human alpha 1(I) procollagen gene (COL1A1) is suppressed by tumour necrosis factor-alpha through proximal short promoter elements: evidence for suppression mechanisms mediated by two nuclear-factorbinding sites.

Authors:  K Mori; A Hatamochi; H Ueki; A Olsen; S A Jimenez
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence.

Authors:  S Murano; R Thweatt; R J Shmookler Reis; R A Jones; E J Moerman; S Goldstein
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts.

Authors:  H Yoshimoto; H Ishihara; A Ohtsuru; K Akino; R Murakami; H Kuroda; H Namba; M Ito; T Fujii; S Yamashita
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

6.  Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures.

Authors:  K Takeda; A Hatamochi; M Arakawa; H Ueki
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

7.  MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.

Authors:  Shengzhi Mu; Bei Kang; Weihui Zeng; Yaowen Sun; Fan Yang
Journal:  Mol Cell Biochem       Date:  2016-04-13       Impact factor: 3.396

8.  Triple Cross-Linked Hyaluronic Acid Based on Tri-Hyal Technique Has More Durable Effect on Dermal Renewal.

Authors:  Rong Chen; Wenbin Yang; Jing Sun; Yuan Liu; Qing An; Feijuan Zhang; Zhuanli Bai; Qi Luan
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-15

9.  Tissue Inhibitor of Metalloproteinase-2 Suppresses Collagen Synthesis in Cultured Keloid Fibroblasts.

Authors:  Teruyuki Dohi; Koichi Miyake; Masayo Aoki; Rei Ogawa; Satoshi Akaishi; Takashi Shimada; Takashi Okada; Hiko Hyakusoku
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-09-22

10.  Regulatory effects of electronic beam irradiation on mir-21/smad7-mediated collagen I synthesis in keloid-derived fibroblasts.

Authors:  Shifeng Li; Wei Liu; Ying Lei; Jianhong Long
Journal:  Biol Open       Date:  2016-11-15       Impact factor: 2.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.